Diabetes complications

A population health analysis of trends in lower extremity amputation secondary to diabetes and peripheral artery disease, 2016–2023

Diabetes Res Clin PractPublished Observational cohort study

Authors' conclusion

Racial, socioeconomic and gender disparities in amputation rates appear to be increasing despite reduced smoking and therapeutic improvements, reflecting increasing diabetes and PAD prevalence. Health systems and community partners should emphasize aggressive prevention including screening, early diagnosis and intensive risk factor management.

Study context

Population
Illinois residents with diabetes and peripheral artery disease (PAD) admitted to non-federal hospitals for lower extremity amputation, 2016–2023; excluded age <34 years, oncology or trauma-related diagnoses, isolated toe amputationsamputation admissions, 193 hospitals
Participants
30,834 amputation admissions
Outcome
Changes in amputation rates and inpatient outcomes
Follow-up
2016–2023
Methodological detailspopulation-based, Illinois Hospital Association COMPdata database
  • Population-based
  • Illinois Hospital Association COMPdata database

Main finding

As reported in the abstract

Amputation admissions · 2016 to 2023

Increase in amputation admissions between 2016 and 2023

65 %

Through foot amputations increase

129.4 %

Hi-Lo ratio decreased from 1.83 to

1.04

Observational data: associations, not effects.

Further findings

Largest percent increases in amputation rates by subgroup · 2016 to 2023

%

Males
+76.1
Non-Hispanic Black patients
+67.5
Residents aged 65 to 74 years among the largest increases

Original publication

A population health analysis of trends in lower extremity amputation secondary to diabetes and peripheral artery disease, 2016–2023. Diabetes Res Clin Pract. Published 24 October 2025. doi:10.1016/j.diabres.2025.112963

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.